P/E ratio for Chemed (CHE)
P/E ratio as of October 2023 (TTM): 34.1
According to Chemed's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 34.0594. At the end of 2021 the company had a P/E ratio of 30.8.
P/E ratio history for Chemed from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 30.8 | 15.94% |
| 2020 | 26.6 | -16.7% |
| 2019 | 31.9 | 44.24% |
| 2018 | 22.1 | -44.36% |
| 2017 | 39.8 | 64.89% |
| 2016 | 24.1 | 5.31% |
| 2015 | 22.9 | 25.5% |
| 2014 | 18.3 | 1.47% |
| 2013 | 18.0 | 24.29% |
| 2012 | 14.5 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 LHC Group LHCG | 82.4 | 142.02% | 🇺🇸 USA |
 Amedisys AMED | > 1000 | 2,963.27% | 🇺🇸 USA |
 Balchem BCPC | 39.8 | 16.78% | 🇺🇸 USA |
 Sensient Technologies
SXT | 17.8 | -47.61% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.